GLENMARK PHARMACEUTICALS INC — Carvedilol Importer Profile
Pharmaceutical Importer · #20 buyer for Carvedilol · $7.6M import value · 266 shipments · UNITED STATES · DGFT Verified
GLENMARK PHARMACEUTICALS INC is the #20 importer of Carvedilol from India with $7.6M in import value and 266 verified shipments. GLENMARK PHARMACEUTICALS INC holds a 0.7% market share in Carvedilol imports based in UNITED STATES. The company sources from 1 verified supplier across 161 formulations shipped to 1 country. Overall, GLENMARK PHARMACEUTICALS INC imports 5 pharmaceutical products worth $2.3M across 4 therapeutic categories.
GLENMARK PHARMACEUTICALS INC — Carvedilol Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Carvedilol to GLENMARK PHARMACEUTICALS INC?
Verified from 266 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLENMARK PHARMACEUTICALS LIMITED | $7.6M | 266 | 100.0% |
GLENMARK PHARMACEUTICALS INC sources Carvedilol from 1 verified Indian supplier based on 266 customs records. The primary supplier is GLENMARK PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
Where Does GLENMARK PHARMACEUTICALS INC Import Carvedilol To?
Destination countries from 266 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $7.6M | 266 | 100.0% |
GLENMARK PHARMACEUTICALS INC imports Carvedilol to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $7.6M.
What Carvedilol Formulations Does GLENMARK PHARMACEUTICALS INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| CARVEDILOL TAB 25MG 500 | $960.8K | 28 |
| CARVEDILOL TAB 6.25MG 500 | $370.0K | 12 |
| CARVEDILOL TAB 12.5MG 500 | $270.5K | 8 |
| CARVEDILOL TAB 6.25MG 500 B/N 19251092 (QTY 13,800 X 3.01 RATE = 41,538.00 USD ) | $163.1K | 4 |
| CARVEDILOL TAB 12.5MG 100 | $116.8K | 6 |
| CARVEDILOL TAB 12.5MG 500 (Qty 6,504 Uni | $110.2K | 4 |
| CARVEDILOL TAB 6.25MG 500 (Qty 20,880 Ra | $100.0K | 2 |
| PHARMACEUTICALS CARVEDILOL TAB 12.5MG 50 | $100.0K | 2 |
| CARVEDILOL TAB 12.5MG 500 (Qty 12,840Uni | $100.0K | 2 |
| CARVEDILOL TAB 12.5MG 500 (Qty 19,536 Un | $100.0K | 2 |
GLENMARK PHARMACEUTICALS INC imports 161 distinct Carvedilol formulations from India. The top formulation is CARVEDILOL TAB 25MG 500 with 28 shipments worth $960.8K.
Regulatory Requirements: Importing Carvedilol into United States
What GLENMARK PHARMACEUTICALS INC and other importers must comply with to import Carvedilol from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Carvedilol
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Carvedilol from India and How Much Does GLENMARK PHARMACEUTICALS INC Import?
India exported $51.6M worth of Carvedilol through 4,750 shipments from 242 suppliers to 98 countries, serving 529 buyers globally. GLENMARK PHARMACEUTICALS INC imports $7.6M of this total, accounting for 0.7% of India's Carvedilol exports with 266 shipments from UNITED STATES. This is verified from 266 customs shipment records covering 161 distinct formulations.
What Is the Average Order Value for GLENMARK PHARMACEUTICALS INC's Carvedilol Imports?
GLENMARK PHARMACEUTICALS INC's average Carvedilol order value is $28.6K per consignment, based on 266 shipments totaling $7.6M. GLENMARK PHARMACEUTICALS INC is based in UNITED STATES and ranks #20 among all Carvedilol importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Carvedilol to GLENMARK PHARMACEUTICALS INC?
GLENMARK PHARMACEUTICALS INC sources Carvedilol from 1 verified Indian supplier: GLENMARK PHARMACEUTICALS LIMITED ($7.6M, 100.0%). This is based on 266 customs records.
How Does GLENMARK PHARMACEUTICALS INC Compare to Other Carvedilol Importers?
GLENMARK PHARMACEUTICALS INC ranks #20 among 529 Carvedilol importers from India with a 0.7% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($19.3M), GLENMARK PHARMACEUTICALS INC., USA ($6.3M), TEVA PHARMACEUTICALS USA, INC ($5.2M). GLENMARK PHARMACEUTICALS INC processed 266 shipments from UNITED STATES.
About GLENMARK PHARMACEUTICALS INC
GLENMARK PHARMACEUTICALS INC imports 5 products worth $2.3M. Beyond Carvedilol, top products include Tacrolimus, Sirolimus, Indomethacin, Saxagliptin. View the complete GLENMARK PHARMACEUTICALS INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Carvedilol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Carvedilol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: GLENMARK PHARMACEUTICALS INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as GLENMARK PHARMACEUTICALS INC's capped import value divided by total capped export value for Carvedilol across all Indian exporters.
- 5.Verified Records: This page is backed by 266 individual customs records matching GLENMARK PHARMACEUTICALS INC importing Carvedilol, covering 161 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 98+ countries, 529+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Carvedilol Import Data for GLENMARK PHARMACEUTICALS INC
Access order-level details, pricing data, supplier connections, and competitive analysis for GLENMARK PHARMACEUTICALS INC's Carvedilol imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
GLENMARK PHARMACEUTICALS INC
Full Company Profile →
5 products · $2.3M total trade · 4 categories
GLENMARK PHARMACEUTICALS INC × Carvedilol
Verified from customs records
Company Overview
Top Products by GLENMARK PHARMACEUTICALS INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for GLENMARK PHARMACEUTICALS INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Carvedilol. For current order-level data, contact TransData Nexus.